Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity

30 Mar 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune Cell Function and Interaction
Share to MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33798549
DOI: 10.1016/j.lfs.2021.119438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicityPMID 33798549Read ↗

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.Semantic proximity Read ↗

TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cellsSemantic proximity Read ↗

Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins.Semantic proximity Read ↗

The 3’ non-coding sequence negatively regulates PD-L1 expression and its regulators are systematically identified in pan-cancerSemantic proximity Read ↗

miRNA-Based Therapeutics in the Era of Immune-Checkpoint InhibitorsSemantic proximity Read ↗

In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.Semantic proximity Read ↗

The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cellsSemantic proximity Read ↗

Noncoding RNA s and immune checkpoints—clinical implications as cancer therapeuticsSemantic proximity Read ↗

Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategiesSemantic proximity Read ↗

NOTCH1 pathway: a molecular target in T-cell cancers?Semantic proximity Read ↗

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapySemantic proximity Read ↗

PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.